“Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3)”, Hematol Meeting Rep, vol. 2, no. 3, Jun. 2009, doi: 10.4081/hmr.v2i3.365.